Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma
Open Access
- 1 May 2021
- journal article
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 7 (3) , 169-173
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and TreatmentEndocrine Reviews, 2016
- Double Trouble: A Case of Primary Hyperparathyroidism and Humoral Hypercalcemia of Malignancy Secondary to Epithelioid Angiosarcoma Occurring in a Single PatientAACE Clinical Case Reports, 2016
- Hypercalcemia of malignancy and new treatment optionsTherapeutics and Clinical Risk Management, 2015
- Hypercalcemia of malignancy: An update on pathogenesis and managementNorth American Journal of Medical Sciences, 2015
- Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial componentJournal of Obstetrics and Gynaecology Research, 2013
- Hypercalcemia of Malignancy with Simultaneous Elevation in Serum Parathyroid Hormone-Related Peptide and 1,25-Dihydroxyvitamin D in a Patient with Metastatic Renal Cell CarcinomaEndocrine Practice, 2009
- PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumorBone, 2007
- Hypercalcemia Associated with CancerNew England Journal of Medicine, 2005
- Tumor-induced hypercalcemia in a patient with extensive soft tissue sarcoma: Effects of bisphosphonate therapy and surgeryJournal of Surgical Oncology, 1996
- Retroperitoneal myxoid liposarcoma presenting with hypercalcaemia.Journal of Clinical Pathology, 1989